about
Inhaled methoxyflurane as a prehospital analgesic in childrenA pilot study of inhaled methoxyflurane for procedural analgesia in childrenGenotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidaseSummary of information on human CYP enzymes: human P450 metabolism data.The role of CYP2B6 in human xenobiotic metabolism.Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane.Liver enzyme induction and inhibition: implications for anaesthesia.Anions and the anaesthetist.Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.Sevoflurane: an ideal agent for adult day-case anesthesia?Inhalational anesthetics.Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.Methoxyflurane: a review with emphasis on its role in dental practice.Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction.In vivo characterisation of a therapeutically relevant self-assembling 18 F-labelled β-sheet forming peptide and its hydrogel using positron emission tomography.Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells.Serum fluoride concentrations, biochemical and histopathological changes associated with prolonged sevoflurane anaesthesia in horses.Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and beta-ionone in rat tissues.Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction.An experimental study of ascorbic acid effects in acute renal failure under general anesthesia.A Multicenter Study Evaluating the Effects of Sevoflurane on Renal Function in Patients With Renal Insufficiency.Effects of sevoflurane anaesthesia on renal function.Extrahepatic Drug-Metabolizing Enzymes and Their Significance
P2860
Q28252095-D50BD926-CDDB-4A23-B0CC-1D8A02E8460AQ28284260-425BEB35-E7E6-402D-8360-D58D4515A0A1Q28289652-5AF685A9-7DA9-4BFA-866C-9297CAD1770CQ32103802-B1D46CAD-4D99-4139-9090-399292177BE8Q33719834-89E441E9-D724-4DA2-B63C-82DFF1658376Q34469754-E2BF5C75-FE92-4932-B268-A769279CF291Q34487131-E17C66A0-CB57-4B57-B1D7-426E0092BA2CQ34548231-F9AB0759-CD18-4F44-817F-E2DA6AB54C88Q35027945-67AB7027-B53E-4C63-83AA-CEDC9D8A33BFQ35194572-898C4B3A-05C9-4405-8082-81F99C3E2D22Q35746755-19DEFAE2-58D5-40E3-B2C0-6ED944B1DD0EQ36227567-718802D6-039B-46F5-A87D-0C16ADA68A0EQ38535168-8D787FEF-231F-41FB-AA6C-FF6E05C63A55Q38746906-C875D2C5-3F3B-454D-8B0D-1D8673FB4BBBQ41898671-657155CE-7C8C-4226-AF3B-54CBDA2F597FQ42726170-EA861D44-E044-4ADC-9E81-55460E258292Q44222010-FF8B1A6A-C5CF-481E-9DA8-DF36FAB83E29Q44502751-79EEE44A-70E2-4263-860C-39317D1DED1BQ46832628-76DD7BC0-CED2-4822-ADC2-9EFE1903FD3AQ47228664-D42EA5AF-DE2E-423E-A923-BA80239F3598Q51417544-5496C8CE-E095-42E1-8E8A-B4630E78D8BDQ51547080-64BAD9FC-FE64-4755-ACFB-969A3D4CC8F4Q57258718-E5A1932F-D23D-4E06-BAC3-E5C327293B9E
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@ast
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@en
type
label
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@ast
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@en
prefLabel
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@ast
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@en
P2093
P1433
P1476
Human Kidney Methoxyflurane and Sevoflurane Metabolism
@en
P2093
Douglas C. Hankins
Evan D. Kharasch
Kenneth E. Thummel
P304
P356
10.1097/00000542-199503000-00011
P407
P577
1995-03-01T00:00:00Z